Advanced Diabetes Technology for Better Glucoregulation, Opportunities and Cost Benefit (“Review on the Reality of a Developing Country”)

The management of diabetes has been revolutionized by the introduction of novel technological treatments and modalities of care, such as continuous glucose monitoring, insulin pump therapy and artificial pancreas (closed-loop). Increased digitalization, and particularly the use of digital medicine products such as connected devices and digital applications, offers many potential benefits such as improved health outcomes, increased care efficiency, and improved quality of life for people with diabetes. However, these devices are unfortunately not universally available largely for economic reasons in developing countries. Treatment of diabetes is aimed at maintaining normoglycemia. That means maintenance of the fasting glucose level at patient with individual goals by achieving through glycated hemoglobin A1c and time in range. However, a significant number of patients with type 1 diabetes and type 2 diabetes use home self-monitors for glucose control. While self-monitoring of blood glucose is useful for measuring blood glucose levels, patients do not regularly check and self-monitoring of blood glucose does not enable many to adequately manage blood glucose levels or capture marked and sustained hyperglycemic excursions. This article presents the advantages of new technologies in the treatment of diabetes, as well as the possibilities, cost-effectiveness and availability for patients with diabetes in developing countries.